A Reflective Checklist

A large proportion of the articles on this website in the past few years were written following inquests of children who took their lives as a consequence of the reckless and inappropriate prescription of psychotropic medications such as SSRI antidepressants and Methylphenidate (Ritalin).

Earlier this week, LinkedIn published A Reflective Checklist for Child Mental Health Professionals who Prescribe Psychotropic Medicines. This had previously been endorsed by the Division of Educational and Child Psychology (DECP) Committee of the British Psychological Society (BPS).

The checklist was compiled by Dave Traxson (left), an experienced Educational and Child Psychologist from the West Midlands. He has a special interest in helping young people develop behavioural self-control and in promoting therapeutic mentoring for staff to use with children. He has made several contributions to the Global Summit on Diagnostic Alternatives.

In his introduction to the checklist, Dave wrote: “The idea for this Reflective Checklist for Mental Health practitioners is for prescribers of psychotropic medications to children in the UK to use as an aide-memoire on their desks to better safeguard the wellbeing of children they work with.”

Here is the checklist:

  1. Are the child’s behavioural differences pervasive, occurring in a wide range of social settings and observed by a range of different individuals in the community?
  2. Are the child’s difficulties severe, enduring, and significantly impairing?
  3. Have there been any stresses in the child’s relationships, social context, and recent history which might explain this pattern of behaviours?
  4. Does the child have presenting behaviours that closely conform to an approved usage for the particular medication being considered at this time?
  5. Is there research evidence on the efficacy and safety of this specific medication with children of the same age, gender, and social grouping?
  6. Are the child’s presenting behaviours significantly impairing in a range of settings to acceptably balance the possible impact on the child’s developing brain and body from the evidence based side effects of the specific medications being considered?
  7. Do the child’s parents and involved professionals see the child’s differences as significant enough to require this medication?
  8. Has a psychological intervention, such as a talking therapy (CBT etc.); a social intervention such as ‘Circle of Friends’ / ‘Buddy System’ or a physical intervention such as participation in sport been tried prior to prescribing this particular psychotropic medication being considered?
  9. Have there been any reported significant adverse side effects from this specific medication with children of the same age, gender and social grouping?
  10. Have you carefully weighed up the short and long-term risks and balanced them against possible benefits?
  11. Have you received valid consent from the parent and the child?
  12. And perhaps the most searching question: If a child in your immediate family or circle of friends had the same presenting behaviours that are in front of you now, would you still be prepared to prescribe this drug?

The article had previously been published in the Psychiatric Times, where Professor Allen Frances (right), a prominent American psychiatrist, commented: “Overwhelmed teachers often recommend that parents take their kids to doctors for medicine when the problem may be more in the classroom than in the kid. Dave Traxson, a child and educational psychologist, and his colleagues in the United Kingdom have come up with a terrific suggestion to help contain the epidemic of careless medication in kids. They have developed a checklist of questions doctors should think about before prescribing psychoactive drugs to children.”

Lisbeth Kortegaard (left) from Hoejbjerg, Denmark, wrote: “Thanks for the check list. I wonder how many children would really need medications after working through this check list? I am a child and adolescent psychiatrist, and as the years go by I find fewer and fewer children really need medications, and more and more do so much better without the meds that didn’t really help in the first place.”

Dave recognises that: “The rapidly increasing prescription rates of psychotropic drugs for children by Child Psychiatrists and Paediatricians in the UK over the last two decades has alarmed many mental health practitioners and professional bodies…as well as colleagues in America where the situation is even more extreme. In some states the prescription rate for Methylphenidate alone is 16% of the total school population which most professionals would want to avoid in the UK.”

It is indisputable that psychotropic medication can cause irreparable harm to children. Although NICE Guidelines state that SSRIs should be given only in extreme circumstances, and only after other strategies have failed, GPs and practitioners at CAMHS are prescribing Fluoxetine (Prozac) as their Plan A, without even considering a Plan B alternative.

Meanwhile, in schools, there are now financial incentives for having a lively or disruptive pupil given an official diagnosis of Special Educational Needs and Disability (SEND), which is often accompanied by a prescription of Ritalin.

In 2016, the United Nations Committee on the Rights of the Child (CRC) published their investigation, to which I was invited to contribute a submission, into Children’s Rights in the UK. Sections 59-62 of the report dealt with mental health. Here, the committee voiced their concerns over the treatment of ADHD:

They reported that: ”The actual number of children that are given methylphenidate or other psychotropic drugs is not available”, and that: “There is reportedly a significant increase in the prescription of psycho-stimulants and psychotropic drugs to children with behavioural problems, including for children under 6 years of age, despite growing evidence of the harmful effects of these drugs.”

One of their recommendations was to: “Ensure that prescription of drugs is used as a measure of last resort and only after an individualized assessment of the best interests of that child, and that children and their parents are properly informed about the possible side effects of this medical treatment and about non-medical alternatives.”

If our children are to flourish and thrive, much more attention must be paid to providing the kind of educational and psychological support that is needed, and less reliance on prescribing drugs that are known to be ineffective and harmful. Dave Traxson’s checklist can be an significant tool for practitioners.

Related Articles:

The ADHD Epidemic

The Lost Children (2014, 2015, 2016 & 2017)

Why we shouldn’t give Prozac to children

Were these children given Prozac?

Pushy Parents and Prozac

Kids in Crisis

Dana’s Human Rights – and ours

Tallulah, aged 15

Tom, aged 14

George, aged 15

Kesia, aged 17

Jade, aged 15

Alice, aged 17

Taylor, aged 9

Jake’s Amendment

Jake, Aged 14 (Part One, Part Two & Part Three)

Jay, aged 17

Ashleigh, aged 14

Benn, aged 17

John, aged 17

Reece, aged 17

Amy, aged 14

Jay, aged 16

Tom, aged 16

Brandon, aged 15

Sophie, aged 13

Rosemary, Ela and Joe

Josie, aged 15

George, aged 18

Pippa, aged 15

Stephen, aged 14

Chloe, aged 17

Daisy, aged 16

Becky, aged 15

Karen, aged 16

George, aged 16

Amelia, aged 16

Matthew, aged 14

Sian, aged 16

Charlie, aged 17

Ellie-Jaye, aged 17

Tiegan, aged 17

Morgan, aged 17

Ellie, aged 15

Aryan, aged 17

Afrika, aged 18

Losing Heather

Losing Rachel



2 Replies to “A Reflective Checklist”

  1. Thanks Brian for this well written and supportive article. I really want to get it out there for prescribers to make use of before writing a scrip.
    Every bit of support helps.

Leave a Reply

Your email address will not be published. Required fields are marked *


This site uses Akismet to reduce spam. Learn how your comment data is processed.